Trials / Completed
CompletedNCT04152941
Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients
Observational Retrospective Cohort Study in Patients With Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated With Olaparib Following Response to Platinium-based Chemotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- ARCAGY/ GINECO GROUP · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a national, multi center, retrospective observational cohort study that will be carried out by reviewing the medical records of patients with relapsed epithelial ovarian, fallopian tube, or peritoneal cancer treated with olaparib following response to platinum-based chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olaparib | Patients with histologically confirmed ovarian cancer, primary peritoneal cancer and / or fallopian-tube cancer treated with olaparib in a real life-setting, between May 2014 to March 2017, whatever the line of therapy |
Timeline
- Start date
- 2018-10-11
- Primary completion
- 2020-02-11
- Completion
- 2020-02-11
- First posted
- 2019-11-06
- Last updated
- 2023-09-06
Locations
28 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04152941. Inclusion in this directory is not an endorsement.